KROS News
Archived Headlines
- US IPO Week Ahead: An empty calendar and a quiet week for the IPO market 04/09/20
- US IPO Weekly Recap: Keros Therapeutics rises 35% as biotechs beat the IPO shutdown 04/09/20
- Hot blooded: Keros Therapeutics prices upsized IPO at $16, the high end of the range 04/07/20
- US IPO Week Ahead: Another biotech plans to take on the IPO market 04/03/20
- US IPO Weekly Recap: Zentalis Pharma defies sell-off as biotech pops 29% 04/03/20
See more
US IPO Week Ahead: The IPO market cools off in a 7 IPO week
Updated Monday, 10/5. Following an active September, seven IPOs and four SPACs are scheduled to raise $2.3 billion in the week ahead. Live TV streaming platform fuboTV (FUBO) plans to raise $150 million at a $1.4 billion...read more
2020 biotech IPOs now average an 80% return from their offer price
The 2020 US biotech IPO class closed Wednesday with an 80% average return from the offering price, a historic run-up for the year's 23 development-stage drug developers. The group has averaged a 36% pop on day one, and then 35% from there. Biotechs make up 70%...read more
US IPO Week Ahead: GAN bets on itself in a 3 IPO week
Updated on 5/4/2020 Three IPOs and one SPAC are scheduled for the week ahead. Internet gambling software provider GAN Limited (GAN) plans to raise $48 million at a $224 million fully diluted market cap after ...read more
The IPO market’s slowest spring since the financial crisis
The 2020 IPO market saw its slowest March and April in over a decade, as volatility essentially shut the IPO window. Just seven IPOs priced during the past two months, a 70% decline from the 15-year average of 23 IPOs. ...read more